Presents a letter commenting on the infection characteristics of hepatitis C virus (HCV) in hemodialysis (HD) patients. Capability of the hepatocyte growth factor serum levels of attenuating liver damage caused by HCV; Association of anti-HCV with higher risk of mortality; Differences on the route of transmission of HCV infection in HD patients.